Panacea Biotec Limited (PANACEABIO.NS)
INR 463.0
(1.47%)
INR 463.0
(1.47%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.59 Billion | 4.59 Billion | 6.59 Billion | 6.17 Billion | 5.37 Billion | 4.52 Billion |
| Cost of Revenue | 4.16 Billion | 2.52 Billion | 3 Billion | 2.28 Billion | 1.74 Billion | 2.02 Billion |
| Gross Profit | 1.42 Billion | 2.07 Billion | 3.59 Billion | 3.89 Billion | 3.62 Billion | 2.49 Billion |
| Operating Expenses | 1.99 Billion | 3.44 Billion | 4.12 Billion | 3.52 Billion | 3.2 Billion | 3.54 Billion |
| Selling, General and Administrative Expenses | 1.64 Billion | 389.8 Million | 757.55 Million | 786.48 Million | 630.67 Million | 552.41 Million |
| Research and Development Expenses | - | 328.2 Million | 358.03 Million | 390.17 Million | 107.08 Million | 255.83 Million |
| Other Expenses | 2.24 Billion | 516.6 Million | 33.97 Million | 20.16 Million | 8.67 Million | 20.85 Million |
| Cost and Expenses | 6.15 Billion | 5.97 Billion | 7.12 Billion | 5.8 Billion | 4.95 Billion | 5.57 Billion |
| Operating Income | - | -1.02 Billion | -484.18 Million | 427.33 Million | 429.26 Million | -1.1 Billion |
| Interest Expense | 35.8 Million | 44.4 Million | 1.79 Billion | 1.84 Billion | 1.73 Billion | 849.69 Million |
| Income Tax Expense | 29.82 Million | 465.5 Million | 3.7 Billion | 19.57 Million | 166.4 Million | 77.07 Million |
| Earnings before Tax | 14.77 Million | 128 Million | 14.48 Billion | -1.44 Billion | -1.71 Billion | 486.15 Million |
| Net Income | -11.73 Million | -337.5 Million | 10.78 Billion | -1.47 Billion | -1.94 Billion | 377.27 Million |
| Earnings Per Share Basic | -0.19 | -5.51 | 176.05 | -24.11 | -31.72 | 6.16 |
| Earnings Per Share Diluted | -0.19 | -5.51 | 176.05 | -24.11 | -31.72 | 6.16 |
| Weighted Average Shares Outstanding | 61.57 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Gross Margin | 0.26 | 0.45 | 0.54 | 0.63 | 0.68 | 0.55 |
| EBIT Margin | -0.01 | -0.10 | -0.00 | 0.14 | 0.17 | -0.18 |
| Profit Margin | -0.00 | -0.07 | 1.64 | -0.24 | -0.36 | 0.08 |
| EBITDA | -47.58 Million | 563.65 Million | 16.73 Billion | 866.06 Million | 456.49 Million | 2.07 Billion |
| Earnings Before Tax Margin | - | -0.22 | -0.07 | 0.07 | 0.08 | -0.24 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.15 Billion | 5.59 Billion | 1.36 Billion | 1.5 Billion | 1.43 Billion | 1.29 Billion |
| Cost of Revenue | 879.5 Million | 4.16 Billion | 969.9 Million | 1.14 Billion | 581.9 Million | 548.6 Million |
| Gross Profit | 277.7 Million | 1.42 Billion | 394.7 Million | 364.2 Million | 848.3 Million | 743.3 Million |
| Operating Expenses | 504.9 Million | 1.99 Billion | 543.2 Million | 456.8 Million | 977 Million | 941.2 Million |
| Selling, General and Administrative Expenses | 504.9 Million | - | 543.2 Million | 456.8 Million | 508.7 Million | 359.7 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 38 Million | 258 Million | 108.1 Million | 56.8 Million | 32.3 Million | 60.8 Million |
| Cost and Expenses | 1.38 Billion | 6.15 Billion | 1.51 Billion | 1.59 Billion | 1.55 Billion | 1.48 Billion |
| Operating Income | -227.2 Million | -567.7 Million | -148.5 Million | -92.6 Million | -96.4 Million | -137.1 Million |
| Interest Expense | 8.7 Million | 35.8 Million | 8.2 Million | 8.5 Million | 9.1 Million | 10 Million |
| Income Tax Expense | -11.7 Million | 29.8 Million | -1.3 Million | 5.5 Million | 5.1 Million | 20.5 Million |
| Earnings before Tax | -170.5 Million | 14.8 Million | -21.2 Million | -16.5 Million | -77.8 Million | 130.3 Million |
| Net Income | -158 Million | -11.7 Million | -14.3 Million | -22.8 Million | -82.9 Million | 109.8 Million |
| Earnings Per Share Basic | -2.58 | - | -0.23 | -0.37 | -1.35 | 1.78 |
| Earnings Per Share Diluted | -2.58 | - | -0.23 | -0.37 | -1.35 | 1.78 |
| Weighted Average Shares Outstanding | 61.25 Million | 61.57 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.25 Million | 61.57 Million | 61.25 Million | 61.25 Million | 61.25 Million | 61.25 Million |
| Gross Margin | 0.24 | 0.26 | 0.29 | 0.24 | 0.59 | 0.58 |
| EBIT Margin | -0.12 | - | -0.04 | -0.00 | -0.00 | -0.03 |
| Profit Margin | -0.14 | -0.00 | -0.01 | -0.02 | -0.06 | 0.08 |
| EBITDA | -139.9 Million | - | -60.4 Million | -1.5 Million | -3.3 Million | -42.3 Million |
| Earnings Before Tax Margin | -0.20 | -0.10 | -0.11 | -0.06 | -0.07 | -0.11 |
5610
5577
CUB
SJS
002098
AUTN